These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2951312)

  • 1. [A study on the veto cells from H-2 recombinant mice and allogeneic bone marrow chimeric mice].
    Ogasawara M
    Hokkaido Igaku Zasshi; 1986 Nov; 61(6):883-91. PubMed ID: 2951312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow cells from allogeneic bone marrow chimeras inhibit the generation of cytotoxic lymphocyte responses against both donor and recipient cells.
    Ogasawara M; Iwabuchi K; Good RA; Onoe K
    J Immunol; 1988 Nov; 141(10):3306-12. PubMed ID: 2972771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of proliferative responses to host Ia antigens in fully allogeneic bone marrow chimeras in mice--sequential analysis of the reactivity and characterization of the cells involved in the response].
    Iwabuchi K
    Hokkaido Igaku Zasshi; 1986 Nov; 61(6):869-82. PubMed ID: 3493963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of protection from graft-vs-host disease in murine mixed allogeneic chimeras. I. Development of a null cell population suppressive of cell-mediated lympholysis responses and derived from the syngeneic bone marrow component.
    Sykes M; Eisenthal A; Sachs DH
    J Immunol; 1988 May; 140(9):2903-11. PubMed ID: 2966200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic restriction specificity of suppressor T cell circuit--analyses by allogeneic bone marrow chimeras].
    Munechika N
    Hokkaido Igaku Zasshi; 1985 Jul; 60(4):593-601. PubMed ID: 2414201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on proliferative responses to host Ia antigens in allogeneic bone marrow chimera in mice: sequential analysis of the reactivity and characterization of the cells involved in the responses.
    Iwabuchi K; Ogasawara K; Ogasawara M; Yasumizu R; Noguchi M; Geng L; Fujita M; Good RA; Onoé K
    J Immunol; 1987 Jan; 138(1):18-25. PubMed ID: 2946776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of primary cytotoxic T lymphocyte responses generated during mixed leukocyte culture with H-2d identical Qa-1-disparate cells.
    Huston DP; Tavana G; Rich RR; Gressens SE
    J Immunol; 1986 Sep; 137(6):1776-81. PubMed ID: 2943800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressor T cells, distinct from "veto cells," are induced by alloantigen priming and mediate transferable suppression of cytotoxic T lymphocyte responses in vivo.
    Owens T; Crispe IN
    J Immunol; 1985 Nov; 135(5):2984-9. PubMed ID: 2413108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes.
    Fink PJ; Rammensee HG; Benedetto JD; Staerz UD; Lefrancois L; Bevan MJ
    J Immunol; 1984 Oct; 133(4):1769-74. PubMed ID: 6236258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressor T cells in allogeneic bone marrow chimeras.
    Leshem B; Lebendiker Z; Weiss L; Slavin S; Kedar E
    Bone Marrow Transplant; 1987 Aug; 2(2):123-32. PubMed ID: 2901877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of cytotoxic T lymphocyte development by a minor stimulating locus-induced suppressor cascade that involves Lyt-1+ suppressor T cells, IA- macrophages, and their factors.
    Chow KP; Battisto JR
    J Immunol; 1988 Feb; 140(4):1005-13. PubMed ID: 2963857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine A and peripheral tolerance. Inhibition of veto cell-mediated clonal deletion of postthymic precursor cytotoxic T lymphocytes.
    Hiruma K; Gress RE
    J Immunol; 1992 Sep; 149(5):1539-47. PubMed ID: 1387142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of in vitro cytotoxic T lymphocyte generation. III. Interactions or regulatory T cell subsets in suppressor and target populations.
    Schwartz A; Gershon RK
    J Mol Cell Immunol; 1984; 1(4):237-52. PubMed ID: 6152894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them.
    Fink PJ; Rammensee HG; Bevan MJ
    J Immunol; 1984 Oct; 133(4):1775-81. PubMed ID: 6332132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of linked suppression in addition to the donor H-2 class I-specific unresponsiveness in recipient T cells by transfusing class I plus class II-disparate, but not class I alone-disparate, bone marrow cells.
    Muraoka S
    Cell Immunol; 1990 Jun; 128(1):261-76. PubMed ID: 1971530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T lymphocyte response to minor H-42a alloantigen in H-42b mice: clonal inactivation of the precursor cytotoxic T lymphocytes by veto-like spleen cells that express the H-42a antigen.
    Ishikawa H; Hino T; Kato H; Suzuki H; Saito K
    J Immunol; 1986 Oct; 137(7):2080-8. PubMed ID: 3489752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of the alloreactive T cell repertoire: K region homology between H-2b T cell precursors and T cell maturation environment is required for the generation of the Kbm6-specific cytotoxic T cell repertoire.
    Gress RE; Hodes RJ
    J Immunol; 1984 May; 132(5):2226-31. PubMed ID: 6201535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recipient micro-environment does not dictate the Igh-V restriction specificity of T cell suppressor inducer factor (TsiF) from allogeneic bone marrow chimera in mice.
    Noguchi M; Ogasawara M; Iwabuchi K; Osgasawara K; Ishihara T; Good RA; Morikawa K; Onoé K
    J Immunol; 1985 Oct; 135(4):2557-61. PubMed ID: 2411802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
    Thiele DL; Calomeni JA; Lipsky PE
    J Immunol; 1987 Oct; 139(7):2137-42. PubMed ID: 3309052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.